Alder Biopharma (ALDR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,796 | -5,395 | -20,613 | -16,738 | -10,829 |
| Depreciation Amortization | 355 | 188 | 935 | 708 | 473 |
| Accounts receivable | 259 | 225 | -188 | 30 | -5 |
| Accounts payable and accrued liabilities | 448 | -518 | 303 | -798 | -1,278 |
| Other Working Capital | -11,118 | -4,495 | -17,072 | -12,439 | -10,496 |
| Other Operating Activity | -319 | 441 | 503 | 1,244 | 1,616 |
| Operating Cash Flow | $-23,171 | $-9,554 | $-36,132 | $-27,993 | $-20,519 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -312 | -20 | -193 | -115 | -92 |
| Purchase Of Investment | -10,045 | 0 | N/A | N/A | N/A |
| Sale Of Investment | 0 | 0 | 5,620 | 4,885 | 3,430 |
| Other Investing Activity | 0 | 0 | 119 | 119 | 0 |
| Investing Cash Flow | $-10,357 | $-20 | $5,546 | $4,889 | $3,338 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 80,547 | 34 | 48 | 16 | 16 |
| Other Financing Activity | 0 | -756 | 0 | 0 | 0 |
| Financing Cash Flow | $80,547 | $-722 | $48 | $16 | $16 |
| Exchange Rate Effect | 11 | 7 | 12 | -1 | -7 |
| Beginning Cash Position | 23,227 | 23,227 | 53,753 | 53,753 | 53,753 |
| End Cash Position | 70,257 | 12,938 | 23,227 | 30,664 | 36,581 |
| Net Cash Flow | $47,030 | $-10,289 | $-30,526 | $-23,089 | $-17,172 |
| Free Cash Flow | |||||
| Operating Cash Flow | -23,171 | -9,554 | -36,132 | -27,993 | -20,519 |
| Capital Expenditure | -312 | -20 | -193 | -115 | -92 |
| Free Cash Flow | -23,483 | -9,574 | -36,325 | -28,108 | -20,611 |